No Data
No Data
Emerging markets stock digest: AVILEN surged significantly, with Immune Biosciences hitting the limit up.
Stalemate. On the 11th, after the close of trading, the performance for the fiscal year ending August 2024 was announced, and it has been in a stalemate even after starting to rise.
Hot stocks digest (morning session): JINSHD, KOZAIDOH HD, Bic Camera, etc.
Cosmos Pharmaceuticals <3349>: 7,729 yen (+409 yen) sharply rebounded. The company announced its first quarter earnings last weekend, with an operating profit of 11.6 billion yen, a 28.8% increase from the same period last year, exceeding the market consensus by about 2 billion yen. The gross profit margin of general food products has significantly improved. The unchanged full-year plan is 31.6 billion yen, a 0.3% increase from the previous year, and there is a conscious expectation of a significant upside. In addition, the same-store sales revenue for September announced at the same time decreased by 4.2% compared to the same month last year.
Ryohin Keikaku, operating profit up by 69.4% to 56.1 billion yen on August 24, financial estimates for August 25 showing a 2.0% decrease to 55 billion yen.
Ryohin Keikaku <7453> announced its financial results for the August 2024 period, with operating revenue increasing by 13.8% year-on-year to 661.677 million yen, and operating profit increasing by 69.4% to 56.135 million yen. Both operating revenue and each stage profit reached record highs. The improvement in operating gross profit margin was due to the effects of domestic price adjustments and the suppression of price reductions. For the August 2025 period, operating revenue increased by 10.9% year-on-year to 734 billion yen, while operating profit decreased by 2% to 55 billion yen.
Wantedly To Go Ex-Dividend On August 28th, 2025 With 20 JPY Dividend Per Share
October 12th (Japan Standard Time) - $Wantedly(3991.JP)$ is trading ex-dividend on August 28th, 2025.Shareholders of record on August 31st, 2025 will receive 20 JPY dividend per share. The ex-
Wantedly: Extraordinary Report
Wantedly: Financial results briefing materials for the fiscal year ending August 2024 (matters relating to business plans and growth potential)
No Data
No Data